Research programme: selective androgen receptor modulators - Dong-A STAlternative Names: DA-4210
Latest Information Update: 22 Jan 2016
At a glance
- Originator Dong-A ST
- Mechanism of Action Androgen receptor modulators
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
- Available For Licensing Yes - Muscular atrophy
Highest Development Phases
- Preclinical Muscular atrophy